GENEQUINE BIOTHERAPEUTICS GMBH

GeneQuine Biotherapeutics designs and develops gene therapies for its clients. The therapies developed by the company aim to treat osteoarthritis. Its product portfolio consists of GQ-201, GQ-202, and GQ-203. GeneQuine Biotherapeutics was founded in 2011 by Stanislav Plutizki and Kilian Guse.
GENEQUINE BIOTHERAPEUTICS GMBH
Industry:
Biopharma Biotechnology Developer Tools Health Care
Founded:
2011-01-01
Address:
Hamburg, Hamburg, Germany
Country:
Germany
Website Url:
http://www.genequine.com
Total Employee:
1+
Status:
Active
Contact:
49 40 766 29 28 51
Total Funding:
9.89 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apache Mobile Non Scaleable Content Euro Microsoft Exchange Online Cloudflare JS CDN JS JQuery CDN
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Current Employees Featured
Stanislav Plutizki COO @ GeneQuine Biotherapeutics GmbH
COO
2018-01-01
Kilian Guse Founder & CEO @ GeneQuine Biotherapeutics GmbH
Founder & CEO
Founder
Investors List
Pacira Pharmaceuticals
Pacira Pharmaceuticals investment in Series A - GeneQuine Biotherapeutics GmbH
Meusinvest (Noshaq)
Meusinvest (Noshaq) investment in Series A - GeneQuine Biotherapeutics GmbH
High-Tech Grunderfonds
High-Tech Grunderfonds investment in Series A - GeneQuine Biotherapeutics GmbH
Pacira Pharmaceuticals
Pacira Pharmaceuticals investment in Debt Financing - GeneQuine Biotherapeutics GmbH
High-Tech Grunderfonds
High-Tech Grunderfonds investment in Seed Round - GeneQuine Biotherapeutics GmbH
IFB Innovationsstarter
IFB Innovationsstarter investment in Seed Round - GeneQuine Biotherapeutics GmbH
Official Site Inspections
http://www.genequine.com Semrush global rank: 6.11 M Semrush visits lastest month: 1.33 K
- Host name: 217-160-0-180.elastic-ssl.ui-r.com
- IP address: 217.160.0.180
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
Genequine.com lookup results from whois.ionos.com server:
- Domain created: 29th-Apr-2011
- Domain updated: 29th-Apr-2024
- Domain expires: 29th-Apr-2025 0 Years, 64 Days left
- Website age: 13 Years, 301 Days
- Registrar Domain ID: 1653441443_DOMAIN_COM-VRSN
- Registrar Url: http://www.ionos.com
- Registrar WHOIS Server: whois.ionos.com
- Registrar Abuse Contact Email: abuse@ionos.com
- Registrar Abuse Contact Phone: +1.6105601459
- Name server:
- NS1029.UI-DNS.BIZ
- NS1029.UI-DNS.COM
- NS1029.UI-DNS.DE
- NS1029.UI-DNS.ORG